MSIP to sponsor new drug development up to non-clinical study with KRW 500 billion within 10 years

The government has attracted the industry as planning to carry out a project to support new drug development up to the non-clinical study phase with KRW 500 billion within 10 years.

Deputy Director Nam-Gyu Cho at the Ministry of Science, ICT and Future Planning(MSIP) introduced the ‘Business for Discovery and Possession of National New Drug Pipelines’ at the Korea Drug Research Association’s 3...